Related Experiment Video
Updated: Jun 23, 2026
10:35
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Increased arterial stiffness in familial combined hyperlipidemia
Martijn C G J Brouwers1, Koen D Reesink, Marleen M J van Greevenbroek
1Department of Internal Medicine and Endocrinology, Maastricht University Medical Centre, Maastricht, The Netherlands. martijn.brouwers@intmed.unimaas.nl
Journal of Hypertension
|April 30, 2009
Summary
Normolipidemic relatives of familial combined hyperlipidemia (FCHL) patients exhibit increased arterial stiffness and plaque prevalence compared to controls. These findings highlight early cardiovascular risks in FCHL families.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Vascular Biology
Background:
- Familial combined hyperlipidemia (FCHL) is a genetic disorder associated with increased cardiovascular risk.
- Early detection of cardiovascular changes in at-risk individuals is crucial for preventative strategies.
Purpose of the Study:
- To investigate arterial stiffness and atherosclerosis markers in normolipidemic relatives of FCHL patients.
- To identify factors associated with arterial stiffness in this population.
Main Methods:
- Ultrasound examination of the common carotid artery was performed on FCHL patients, their normolipidemic relatives, and healthy controls.
- Arterial stiffness was assessed using the stiffness index alpha, and plaque presence was recorded.
Main Results:
- Normolipidemic relatives showed higher arterial stiffness and plaque prevalence than controls, but lower than FCHL patients.
- Arterial stiffness was independently associated with age and FCHL family status.
- Atherosclerosis markers were independently associated with age, male sex, pulse frequency, and LDL cholesterol.
Conclusions:
- Individuals with a predisposition to FCHL, including normolipidemic relatives, exhibit heightened arterial stiffening and atherosclerosis.
- These findings suggest increased cardiovascular risk in FCHL families, extending beyond diagnosed patients.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...